MSF at the 70th World Health Assembly

Photograph by UN Photo/Eskinder Debebe

MSF activities at the seventieth session of the World Health Assembly (WHA), Geneva, Switzerland, 22 - 31 May 2017

MSF Interventions

MSF interventions will be posted as they are delivered.

Agenda item 12.1: Research and development for potentially epidemic diseases – a blueprint for research and development preparedness and rapid research response

Agenda item 12.2: Antimicrobial resistance (AMR)

Agenda item 13.4: Evaluation and review of the global strategy and plan of action on public health, innovation and intellectual property (GSPOA)

Agenda item 13.3: Addressing the global shortage of, and access to, medicines and vaccines

Agenda item 13.5: Follow-up of the report of the Consultative Expert Working Group on Research and Development - Financing and Coordination (CEWG report)

Agenda item 14.1: Global Vaccine Action Plan (GVAP)

Agenda item 17: Progress Report - Global strategy and targets for tuberculosis prevention, care and control after 2015

MSF Background Documents

Agenda Item 12.2 - Antimicrobial Resistance

Agenda Item 14.1 - Global Vaccine Action Plan (GVAP)

Medical Research and Development

Side Events: Responding to the Challenge of Antimicrobial Resistance: Perspectives of Civil Society, Intergovernmental Organisations and Developing Countries

22 May 2017 17:45 - 18:45, Palais des Nations, Room IX

Speakers:

Viviana Munoz
Coordinator, Development, Innovation and Intellectual Property Programme - South Centre (Moderator/Chair)

Els Torreele
Executive Director - Médecins Sans Frontières Access Campaign, MSF

Garance Upham
Deputy Executive Secretary - WAAAR, and member of Medicus Mundi International

Anthony So
Head of the Strategic Policy Programme - ReAct, North America

Michelle Childs
Head of Policy Advocacy - Drugs for Neglected Diseases initiative, Latin America

Dr Sumit Seth
First Secretary - Permanent Mission of India

Dr Nithima Sumpradit
Senior Pharmacist - Thailand Food and Drug Administration

Sponsored by Médecins Sans Frontières (MSF); Drugs for Neglected Diseases initiative (DNDi); Health Action International (HAI); Medicus Mundi International Network (MMI). With the support of the South Centre and ReAct - Action on Antibiotic Resistance.